In an interview at the 44th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), held September ...
Q3 2026 delivered advances in some closely watched pipeline products.
Mfazo Hove, MD, FRCOphth, a consultant ophthalmologist based in London, has a personal perspective on the trifocal ...
Artificial intelligence (AI) is set to reshape multiple corners of eye care, according to Jai Parekh, MD, MA, FAAO, who ...
The US Food and Drug Administration (FDA) recently accepted Nanoscope Therapeutics’ biologics license application (BLA) for ...
Radhika Rampat, MBBS, FRCOphth, discusses how AI is already shaping intraocular lens selection and keratoconus screening, and ...
Two-year data presented at ESCRS 2026 show the ELIOS excimer laser procedure sustained IOP reduction and kept most glaucoma ...
At ESCRS 2026, Zoltan Z. Nagy, MD, reported that femtosecond laser trabeculotomy (FLigHT) cut intraocular pressure by 27% at 48 months in open-angle glaucoma, with a stable, incision-free safety ...
ESCRS 2026 real-world data: aceclidine (VIZZ; LENZ Therapeutics) drops show fast onset, high satisfaction for presbyopia.
Majda Hadziahmetovic, MD: MacTel type 2 is a slowly progressive disease. The hallmark of the disease is chronic neurodegeneration of the outer retina, including Müller cell dysfunction, photoreceptor ...
The authors of a review of 16 gene therapy trials for inherited retinal diseases explain why the pediatric evidence base remains thin and argue that individual-level, age-stratified reporting is the ...
A new review conducted by Polish investigators showed that evidence obtained using various modalities has taken center stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results